A Clinical Trial to Assess the Safety of SOR102 in Healthy Participants and Patients With Ulcerative Colitis
Clinical trial NCT06080048 · COMPLETED
Trial details
- NCT number
- NCT06080048
- Sponsor
- Sorriso Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-24
- Primary completion
- 2024-10-16
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.